Depositary receipts

Wolters Kluwer to host its 2021 Audit Talks LIVE virtual conference on June 1-2

Retrieved on: 
Wednesday, April 14, 2021

b'Today, Wolters Kluwer Tax & Accounting announced that the 5th edition of its complimentary Audit Talks LIVE virtual conference will take place on June 1-2, 2021.

Key Points: 
  • b'Today, Wolters Kluwer Tax & Accounting announced that the 5th edition of its complimentary Audit Talks LIVE virtual conference will take place on June 1-2, 2021.
  • The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,200 people worldwide.
  • Wolters Kluwer has a sponsored Level 1 American Depositary Receipt (ADR) program.
  • The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210414005157/en/\n'

Technip Energies Announces Publication Date for First Quarter 2021 Financial Results and Conference Call

Retrieved on: 
Friday, April 9, 2021

Technip Energies (PARIS:TE) will issue its first quarter 2021 financial results on Thursday April 22, 2021 at 7 a.m. Paris time.

Key Points: 
  • Technip Energies (PARIS:TE) will issue its first quarter 2021 financial results on Thursday April 22, 2021 at 7 a.m. Paris time.
  • The Company will also host its first quarter 2021 results conference call and webcast on Thursday, April 22, 2021, at 1 p.m. Paris time.
  • The company benefits from its robust project delivery model supported by extensive technology, products and services offering.
  • Technip Energies is listed on Euronext Paris with American depositary receipts (ADRs) trading over-the-counter in the United States.

Morgan Stanley Announces Redemption in Whole of Series J Preferred Stock and Depositary Shares Representing Series J Preferred Stock

Retrieved on: 
Monday, March 15, 2021

Morgan Stanley today announced that it will redeem in whole its outstanding Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J, liquidation preference $25,000 per share (617474309) (the Series J Preferred Stock), and the depositary shares, each representing a 1/25th ownership interest in a share of Series J Preferred Stock (CUSIP 617474AA9) (the Series J Depositary Shares), on April 15, 2021 pursuant to the optional redemption provisions provided in the documents governing such Series J Preferred Stock and Series J Depositary Shares.

Key Points: 
  • Morgan Stanley today announced that it will redeem in whole its outstanding Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series J, liquidation preference $25,000 per share (617474309) (the Series J Preferred Stock), and the depositary shares, each representing a 1/25th ownership interest in a share of Series J Preferred Stock (CUSIP 617474AA9) (the Series J Depositary Shares), on April 15, 2021 pursuant to the optional redemption provisions provided in the documents governing such Series J Preferred Stock and Series J Depositary Shares.
  • Beginning on the redemption date, the Series J Depositary Shares will no longer be deemed outstanding and dividends shall cease to accrue on the Series J Depositary Shares.
  • The Series J Depositary Shares are held through The Depository Trust Company (DTC) and will be redeemed in accordance with DTC procedures.
  • This press release does not constitute a notice of redemption under the certificate of designation governing the Series J Preferred Stock or the deposit agreement governing the Series J Depositary Shares.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Tencent Holdings Limited (TCEHY) on Behalf of Investors

Retrieved on: 
Friday, March 12, 2021

Law Offices of Howard G. Smith announces an investigation on behalf of Tencent Holdings Limited ("Tencent" or the "Company") (OTC: TCEHY ) investors concerning the Companys possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Tencent Holdings Limited ("Tencent" or the "Company") (OTC: TCEHY ) investors concerning the Companys possible violations of federal securities laws.
  • On this news, the Companys American Depositary Receipts (ADRs) price fell as much as $7, or nearly 8%, during intraday trading on March 12, 2021.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20210312005520/en/

SOS Shareholder Alert – SOS Limited Investors Who Have Suffered Losses Greater Than $50,000 Encouraged To Contact Kehoe Law Firm, P.C.

Retrieved on: 
Wednesday, March 10, 2021

is investigating potential securities claims on behalf of investors of SOS Limited (SOS or the Company) (NYSE: SOS) to determine whether the Company engaged in securities fraud or other unlawful business practices.

Key Points: 
  • is investigating potential securities claims on behalf of investors of SOS Limited (SOS or the Company) (NYSE: SOS) to determine whether the Company engaged in securities fraud or other unlawful business practices.
  • On February 26, 2021, SeekingAlpha reported that Hindenburg Research reported that SOS drop[ped] 17% after Hindenburg Research [said] its short on the stock, noting [SOSs] significant regulatory risk.
  • On this news, SOS's American Depositary Receipt ("ADR") price fell$1.27, or 21.03%, closing at$4.77per ADR onFebruary 26, 2021.
  • INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, SOS SECURITIES AND SUFFERED LOSSES GREATER THAN $50,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRMS SECURITIES CLASS ACTION QUESTIONNAIRE OR CONTACT KEVIN CAULEY, DIRECTOR, CLIENT RELATIONS, (215) 792-6676, EXT.

Ruhnn Sets Record Date for Dissemination of Transaction Statement for "Going Private" Transaction

Retrieved on: 
Wednesday, March 10, 2021

Record holders of the Company's ordinary shares (including shares represented by American Depositary Shares of the Company (each, an "ADS")) will each receive a copy of the Schedule 13E-3.

Key Points: 
  • Record holders of the Company's ordinary shares (including shares represented by American Depositary Shares of the Company (each, an "ADS")) will each receive a copy of the Schedule 13E-3.
  • The merger is currently expected to close in April 2021 pursuant to the terms and conditions set forth in the Merger Agreement.
  • Ruhnn pioneered the commercialization of the KOL ecosystem in China, and operates under both platform and full-service models.
  • These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements.

HMS Group: Buy-back Programme Results

Retrieved on: 
Tuesday, March 9, 2021

Inna Kelekhsaeva, Deputy Head of Capital markets, on telephone: +7 (495) 730-6601, or email: [email protected]

Key Points: 
  • Inna Kelekhsaeva, Deputy Head of Capital markets, on telephone: +7 (495) 730-6601, or email: [email protected]
    HMS Group is the leading pump and compressor manufacturer, as well as the provider of flow control solutions and related services for the oil and gas, petrochemistry, nuclear and thermal power generation, water and wastewater sectors in Russia and the CIS headquartered in Moscow, Russia.
  • HMS Group's products are mission-critical elements of projects across a diverse range of industries.
  • HMS has a listing on the London Stock Exchange in the form of global depositary receipts (LSE: HMSG).
  • http://ar2019.grouphms.com
    Information published in press releases was accurate at the time of publication but may be superseded by subsequent releases or other information.

Biofrontera AG Announces Pricing of US$8.9 Million Firm Commitment Public Offering of American Depositary Shares

Retrieved on: 
Wednesday, February 24, 2021

Leverkusen, Germany, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (Biofrontera or the Company), an international biopharmaceutical company, today announced the pricing of a U.S. underwritten public offering of 1,334,002 American Depositary Shares, or ADSs, at an offering price of $6.68 per ADS.

Key Points: 
  • Leverkusen, Germany, Feb. 23, 2021 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (Biofrontera or the Company), an international biopharmaceutical company, today announced the pricing of a U.S. underwritten public offering of 1,334,002 American Depositary Shares, or ADSs, at an offering price of $6.68 per ADS.
  • Each ADS represents two of Biofronteras ordinary shares, nominal value 1.00 per share.
  • The Company expects to receive aggregate gross proceeds of approximately $8.9 million from this offering, before deducting underwriting discounts, commissions and other related expenses.
  • In addition, the registration statement, including the prospectus supplement, is available to the public at www.sec.gov or www.biofrontera.com .

BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares

Retrieved on: 
Tuesday, February 23, 2021

CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced it has priced an underwritten public offering of4,622,000 American Depositary Shares, each representing two ordinary shares, at an offering price of$8.50 per American Depositary Share.

Key Points: 
  • CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced it has priced an underwritten public offering of4,622,000 American Depositary Shares, each representing two ordinary shares, at an offering price of$8.50 per American Depositary Share.
  • The gross proceeds from the offering will be approximately $39,287,000, before deducting underwriting discounts and commissions and estimated offering expenses.
  • BrainsWay has also granted the underwriters a 30-day option to purchase up to an additional693,300 American Depositary Shares on the same terms and conditions.
  • The closing of the offering is expected to take place on February 25, 2021, subject to the satisfaction of customary closing conditions.

BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares

Retrieved on: 
Monday, February 22, 2021

CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd.(NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it intends to offer American Depositary Shares, each representing two ordinary shares, in an underwritten public offering.BrainsWay also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the American Depositary Shares sold in the offering.

Key Points: 
  • CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) -- BrainsWay Ltd.(NASDAQ & TASE: BWAY) (BrainsWay or the Company), a global leader in the advanced noninvasive treatment of brain disorders, today announced that it intends to offer American Depositary Shares, each representing two ordinary shares, in an underwritten public offering.BrainsWay also intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the American Depositary Shares sold in the offering.
  • All of the American Depositary Shares, and the underlying ordinary shares, will be offered byBrainsWay.
  • The proposed offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
  • The offering of the American Depositary Shares will be made by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.